SCHEMBL29966720

SCHEMBL29966720

O=C1COc2ccccc2O1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 1/20 0.46
ITGB2 P05107 1/20 0.46
ICAM1 P05362 1/20 0.46
ITGAL P20701 1/20 0.46
LMNA P02545 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
MAOB P27338 3/20 0.41
MAOA P21397 2/20 0.41
CRHBP P24387 2/20 0.41
CRHR2 Q13324 2/20 0.41
HTT P42858 1/20 0.41
TSHR P16473 2/20 0.40
PKM P14618 1/20 0.40
DAPK3 O43293 1/20 0.38
RET P07949 1/20 0.38
PRKACA P17612 1/20 0.38
GRK5 P34947 1/20 0.38
CDK8 P49336 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL279547 1.00 ABCG2 (0.46) ABCG2ITGB2ICAM1ITGALLMNA
SCHEMBL1615985 0.80 MAOB (0.52) ABCG2ITGB2ICAM1ITGALLMNA
SCHEMBL15026854 0.79 DHODH (0.40) SMN1; SMN2NPC1RAB9AMAOBMAOA
SCHEMBL7754901 0.78 SMN1; SMN2 (0.61) ABCG2ITGB2ICAM1ITGALLMNA
SCHEMBL15763902 0.77 MAOA (0.46) ABCG2ITGB2ICAM1ITGALMAOB
SCHEMBL868520 0.77 ABCG2 (0.52) ABCG2ITGB2ICAM1ITGALLMNA
SCHEMBL14447058 0.77 PKM (0.42) SMN1; SMN2MAOBMAOATSHRPKM
SCHEMBL7256530 0.76 MAOA (0.46) LMNASMN1; SMN2NPC1RAB9AMAOB
SCHEMBL31540329 0.76 MAOA (0.46) LMNASMN1; SMN2NPC1RAB9AMAOB
SCHEMBL5045846 0.74 MAOA (0.50) ABCG2ITGB2ICAM1ITGALLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108602809-B Isoxazolidine derived inhibitors of receptor interacting protein kinase 1(RIPK 1) 戴纳立制药公司 2022-09-30 CN disclosed